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The excellent sensitivity and specificity of right upper quadrant (RUQ) ultrasound for gallbladder pathology in
patients with abdominal pain is heavily relied upon in routine diagnostic evaluation. The hour-to-hour timing of this
test in a patient with fluctuating symptoms is not widely recognized as having a significant impact on its sensitivity.
However, we present a case report describing the essential role of symptom-timed point-of-care ultrasound in making
an elusive diagnosis of transient cholecystalgia in a patient with RUQ pain and congestive heart failure (CHF). This case
also demonstrates an important etiology of RUQ pain in patients with CHF beyond that of congestive hepatopathy. A
review of the related entities of acalculous cholecystitis, congestive hepatopathy, and diffuse gallbladder wall
thickening is provided.
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A 47-year-old Ethiopian woman with a history of rheum-
atic heart disease resulting in severe mitral and tricuspid
regurgitation, pulmonary hypertension, congestive heart
failure, and atrial fibrillation presented with 3 days of
cough, increased shortness of breath, and myalgias.
Vital signs on admission were notable for a temperature
of 99.7 °F and tachycardia (heart rate: 110 to 120 bpm).
Examination findings included the expected cardiac
murmurs and mild expiratory wheeze. EKG showed
atrial fibrillation. Laboratory evaluation was notable for an
unremarkable complete blood count and basic metabolic
panel, normal troponin I, and mildly elevated brain natri-
uretic peptide of 296 pg/mL (normal range <150 pg/mL).
Chest X-ray showed cardiomegaly with no acute infiltrate.
A point-of-care ultrasound (POCUS) exam (Figure 1,
Timeline = ‘POCUS #1’) was performed by the internal
medicine resident with an ultrasound mentor and showed
a bilateral pulmonary A-profile (normal) without an
interstitial process (e.g., cardiogenic pulmonary edema)* Correspondence: c.n.desautels@gmail.com
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in any medium, provided the original work is por consolidation, normal left ventricular systolic function,
massive biatrial enlargement, severe mitral and tricuspid
regurgitation, a small pericardial effusion, and a 2.4-cm in-
ferior vena cava with 10% inspiratory collapse. A diagnosis
of influenza was initially suspected given the community
prevalence and the patient's residence in a shelter where
others had been ill. Empiric treatment with oseltamivir
was initiated. However, rapid influenza swab and subse-
quent PCR were both negative.
On hospital day 2, the patient had fever to 101 °F and
complained of increasing right upper quadrant (RUQ)
abdominal pain. Laboratory testing revealed an elevated
bilirubin of 1.5 mg/dL (0.6 mg/dL direct component)
and alkaline phosphatase of 146 IU/L (normal range
<136 IU/L). Aminotransferase levels were normal. It was
noted that the patient had been admitted 1 month prior
with RUQ abdominal pain and vomiting at which time a
formal diagnostic ultrasound showed gallstones, a thick-
ened gallbladder wall (8 mm), and pericholecystic fluid
consistent with acute cholecystitis. General surgery and
gastroenterology had recommended cholecystectomy
after her congestive heart failure had been medically
and/or surgically optimized, which had not yet occurred.
The differential for her fever was thus broadened from
solely a pulmonary source to include acute cholecystitisis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 Timeline of hospital events and severity of right upper
quadrant pain. HD, hospital day; POCUS, point-of-care ultrasound;
RUQ, right upper quadrant; US, ultrasound; GB, gallbladder; SMS,
sonographic Murphy sign. The cross symbol represents the patient’s
pain level.
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metronidazole, ceftriaxone, and azithromycin for coverage
of pneumonia as well as a possible biliary etiology.
Diuretics were held due to hypotension and concern
for early sepsis.
A formal RUQ ultrasound (Figure 1, Timeline = ‘Formal
RUQ US #1’) was obtained that afternoon, 8 h after bed-
side assessment of the patient, and showed a few small
stones within the gallbladder, a normal gallbladder wall,
no pericholecystic fluid, no ductal dilatation (Figure 2),
and a negative sonographic Murphy sign. Given this
imaging result, metronidazole was discontinued and
alternative etiologies for abdominal pain were added
back to the differential.On hospital day 4, the patient complained of recurrent,
severe RUQ and epigastric pain. Exam revealed severe
tenderness to palpation in the RUQ and voluntary guard-
ing, a significant change from the previous day. A POCUS
exam (Figure 1, Timeline = ‘POCUS #2’) was repeated by
the internal medicine resident with an ultrasound mentor
and showed bilateral diffuse pulmonary B-lines (interstitial
pattern) consistent with new pulmonary edema. Despite
the unremarkable formal RUQ ultrasound 42 h prior,
POCUS at the time of her recurrent RUQ pain revealed a
markedly abnormal gallbladder with wall thickening
to 8 mm, narrowing of the gallbladder neck due to
edema, a small non-obstructing gallstone, a normal
common bile duct, subserosal edema, and perichole-
cystic fluid (Figure 3). A positive sonographic Murphy
sign was demonstrated when the patient was asked to
‘push with the ultrasound probe and find where it hurts
most’ and the probe was placed directly over the gallblad-
der fundus.
Metronidazole was resumed, and general surgery and
gastroenterology were consulted to assist in the manage-
ment of acute cholecystitis. Diuresis was resumed in light
of the POCUS findings supporting new pulmonary edema.
A repeat formal RUQ ultrasound (6 h later) (Figure 1,
Timeline = ‘Formal RUQ US #2’) confirmed new marked
echogenic gallbladder wall thickening (decreased to 6 mm
with diuresis between POCUS and the formal study),
pericholecystic fluid, and a normal common bile duct
with no impacting cholelithiasis (Figure 4). The formal
RUQ ultrasound impression was ‘acute cholecystitis.’
Cholecystectomy versus percutaneous cholecystostomy
was recommended, pending the outcome of cholescinti-
graphy and the patient's overall medical stability.
Cholescintigraphy was obtained on hospital day 5
following significant diuresis and was negative for acute
cholecystitis. Given this, and the fact that the patient was
improving and laboratory abnormalities had normalized,
gastroenterology and general surgery recommended on-
going conservative management. Attention turned toward
optimization of the patient's congestive heart failure as the
cause of secondary cholecystalgia. Diuresis was increased
on hospital day 7. By the following day, the patient's
weight had decreased by 2.8 kg; she was feeling much
improved and exam revealed only mild, vague right
upper quadrant tenderness. POCUS exam (Figure 1,
Timeline = ‘POCUS #3’) was again repeated and showed
significant improvement, without gallbladder wall thicken-
ing or sonographic Murphy sign (Figure 5). The patient
was discharged without RUQ pain after optimization of her
volume status without plans for future cholecystectomy.
Background
The initial differential diagnosis for this patient's right
upper quadrant pain included acute gallstone-mediated
Figure 2 Formal right upper quadrant ultrasound #1. (A) Long and (B) short axis views showing a few small stones within the gallbladder,
with no gallbladder wall thickening or pericholecystic fluid.
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hepatopathy. The entity of transient cholecystalgia,
fluctuating in real time with volume status, was not
initially considered. This led to unnecessary testing
for alternative etiologies, plans for cholecystectomy,
and significant confusion for the patient and pro-
viders when the initial formal RUQ ultrasound did
not corroborate the bedside physical exam and
point-of-care ultrasound. A brief review of the con-
sidered etiologies of RUQ pain and discussion of the
appropriate weight we should place on our clinical
and imaging diagnostic tests for the gallbladder
follows.Figure 3 POCUS #2. (A) Long and (B) short axis views of the gallbladder
edematous narrowing of the gallbladder neck. (C) IVC measuring 2 cm wit
indicating volume overload. (D) Diffuse pulmonary B-lines consistent withAccuracy of gallbladder diagnostics
The right upper quadrant ultrasound is the most com-
monly used imaging modality in the evaluation of gall-
bladder disease. The test's accuracy for acute cholecystitis
has been debated due to the presence of verification bias
[1,2]. A meta-analysis of ultrasound's accuracy for acute
cholecystitis found a sensitivity of 94% and specificity of
78%. When the results were adjusted for verification bias,
the sensitivity decreased to 88% and specificity increased
to 80%. The authors recommended using estimates be-
tween the adjusted and unadjusted values. Radionucleo-
tide scanning has better sensitivity (97%) and specificity
(90%) for acute cholecystitis [1].showing abnormal gallbladder wall thickening to 0.78 cm with
h <10% inspiratory collapse and associated hepatic vein engorgement
interstitial edema.
Figure 4 Formal right upper quadrant ultrasound #2. (A) Formal ultrasound long axis and (B) short axis views confirming gallbladder wall
thickening (0.58 cm, 6 h after bedside ultrasound and initiation of diuresis).
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ultrasound because our clinical and laboratory testing
alone do not have the power to rule in or out the diag-
nosis of acute cholecystitis. The negative likelihood ratio
(LR) of RUQ tenderness is 0.4 (95% confidence interval
0.2 to 1.1), representing the most helpful clinical finding
in ruling out acute cholecystitis. However, lack of RUQ
tenderness is probably weaker than this for excluding
acute cholecystitis when studies are adjusted for verifica-
tion and spectrum bias. The positive LR of the Murphy
sign at 2.8 (0.8 to 8.6) is the most helpful finding for
strengthening a diagnosis of acute cholecystitis and ap-
pears to be even stronger when the data are adjusted
for verification and spectrum bias. Notably, the 95%
confidence intervals for both of these likelihood ratios
cross 1. The ‘clinical impression’ of cholecystitis, which
includes an unspecified combination of history, physical
exam, and laboratory findings, results in the best test with
an estimated positive LR of 25 to 30 [2].
In the case of our patient, the presence of gallstones,
gallbladder wall thickening, and a positive sonographic
Murphy sign has extremely high positive predictive value
(98.5%) for a gallbladder requiring surgical intervention
[3]. However, she did not require cholecystectomy once
the secondary nature of her gallbladder abnormality was
confirmed.Figure 5 POCUS #3. (A) Long axis and (B) short axis views showing impro
wall thickness measuring 0.15 cm.Acalculous cholecystitis
Acute acalculous cholecystitis (ACC) remains a menacing
diagnosis that carries a mortality rate of at least 30%
[4]. Though traditionally associated with critical illness,
trauma, burns, and the post-operative period, ACC can
occur in a variety of other scenarios. It has been hypothe-
sized that major contributing factors include bile stasis
and gallbladder ischemia, followed by secondary infection
with enteric pathogens. Bile stasis has been attributed
to volume depletion, opioid-induced sphincter of Oddi
spasm, gastrointestinal hypomotility, and positive-pressure
mechanical ventilation. Gallbladder ischemia may be due
to systemic hypotension, possibly exacerbated by increased
intraluminal pressure from bile stasis, which together de-
crease the gallbladder perfusion pressure [5,6]. ACC can
occur in the setting of congestive heart failure (CHF), where
the gallbladder perfusion pressure presumably suffers due
to decreased cardiac output and elevated venous pressures
[4,7,8]. Unlike the scenario presented in our case, ACC is
typically not transient.
The pathogenesis of ACC involves inflammation and
necrosis of the gallbladder in the absence of an obstruct-
ing gallstone. Signs and symptoms include fever, anorexia,
nausea, vomiting, RUQ or upper abdominal tenderness,
and Murphy sign (if the patient is able to communicate
pain). Laboratory abnormalities include leukocytosis andvement in gallbladder wall thickening after diuresis, with gallbladder
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transferases. Unfortunately, none of these findings are
particularly sensitive or specific in the affected patient
population, and diagnosis relies heavily on the physi-
cian's assessment of the overall clinical picture [2,7].
Ultrasonography is the preferred test for diagnosis due
to the typical location of these patients in the intensive
care unit; however, the test has a sensitivity ranging from
30% to 100% [6]. Radionucleotide scanning, more cum-
bersome in sick patients and fraught with false positives,
has better sensitivity for ACC with values ranging from
67% to 100% [6] and a review targeting a sensitivity of
91% [9]. The treatment is surgical, with cholecystectomy
or percutaneous cholecystostomy in addition to antibiotic
therapy.
Congestive hepatopathy
Congestive hepatopathy, a common diagnosis in patients
with decompensated heart failure and RUQ pain, is a
well-established clinical syndrome that can result from
any cause of right heart failure. Elevated central venous
pressure in congestive heart failure is transmitted to the
hepatic veins and to the venules draining hepatic acini,
and these increased pressures can result in atrophy of
hepatocytes and perisinusoidal edema that impairs diffu-
sion of oxygen and nutrients [10,11].
Patients with hepatic congestion are usually asymp-
tomatic but can present with RUQ pain attributed to
stretching of the liver capsule, usually seen during acute
exacerbations of congestive heart failure [12]. The most
common laboratory abnormalities attributed to congestive
hepatopathy in patients with chronic CHF are decreased
albumin, elevated serum bilirubin, and elevated alkaline
phosphatase [13]. Generally, when abnormalities are
present, they are mild: serum bilirubin is typically less
than 3 mg/dL, alkaline phosphatase is typically normal
or only minimally elevated, and aminotransferases are
usually normal and rarely greater than two times the
upper limit of normal [14,15]. However, there is some
evidence that in more severe congestive heart failure
(on the basis of cardiac index ≤1.5 L/min/m2), more
significant abnormalities in liver function tests are
seen, including aminotransferase elevations >400 U/L [15].
One study found that elevated serum bilirubin was an inde-
pendent predictor of adverse cardiovascular outcomes and
all-cause mortality in patients with chronic CHF [13].
The typical ultrasound findings in congestive hepato-
pathy are non-specific and can include a dilated, non-
collapsible inferior vena cava, hepatomegaly, ascites,
and Doppler waveform abnormalities in the portal
veins. The right upper quadrant ultrasound is primarily
utilized to rule out other causes of RUQ pain [16,17].
Once identified, management of congestive hepatopa-
thy primarily involves treatment of the underlying heartdisease, including careful diuresis and efforts to avoid
decreasing cardiac output.
Diffuse gallbladder wall thickening
While heart failure can cause congestive hepatopathy, it
is also known to be a cause of diffuse gallbladder wall
thickening. This finding is non-specific and can occur in
many other states including acute cholecystitis, cirrhosis,
hypoalbuminemia, adenomyomatosis, malignancy, hepa-
titis, pancreatitis, etc. The diffuse wall thickening related
to elevated portal and systemic venous pressures such as
in cirrhosis and heart failure is typically not thought to
cause pain and a positive Murphy sign [18-21]. In our
patient, a definite focal Murphy sign was present at the
time of the wall thickening (and pain symptoms) and
resolved with resolution of wall thickening.
Conclusions
This case describes an important additional diagnosis to
consider for the common clinical presentation of RUQ
pain in a patient with congestive heart failure. Specifically,
it illustrates the under-recognized entity of transient sec-
ondary cholecystalgia (gallbladder wall thickening and
sonographic Murphy sign) fluctuating hour-by-hour with
the patient's right-sided filling pressures.
This was a challenging diagnostic dilemma made more
complicated by the discordance between the physicians'
bedside clinical assessment and the available imaging re-
sults. RUQ abdominal pain, fever, nausea, and laboratory
abnormalities all suggested the gallbladder as the source
of the patient's pain. When the result of the formal RUQ
ultrasound was unexpectedly normal, the clinical team
found themselves reconsidering their diagnosis because
of their confidence in the test's excellent sensitivity. How-
ever, the availability of point-of-care ultrasound allowed
physicians familiar with the clinical scenario to obtain
real-time imaging when symptoms suggestive of gallblad-
der pathology recurred within hours of the normal formal
RUQ ultrasound, maximizing the sensitivity of the test
and subsequently avoiding the cost and risk of further
diagnostic evaluation.
Once abnormal gallbladder wall thickening and positive
sonographic Murphy sign were identified, the physicians
initially suspected acalculous cholecystitis. This would
have represented an atypical presentation of the diagnosis
as the patient was neither critically ill nor recovering from
surgery; though, as noted above, ACC can occur second-
ary to CHF, medications, nil per os status, or other sys-
temic illness. However, the ability to perform follow-up
POCUS exams allowed the clinical team to visualize rapid
resolution of gallbladder wall thickening correlating in real
time with diuresis. This confirmed a secondary cause of
the gallbladder findings and resulted in a non-surgical
intervention.
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pain was actually infectious cholecystitis and that ces-
sation of metronidazole resulted in the increased pain
on hospital day 4 (Figure 1, Timeline = ‘HD #4, 11:30’)
is unlikely. Metronidazole was held for at least four
times its half-life; thus, symptoms probably would have
recurred sooner if this were infectious cholecystitis.
Additionally, though RUQ abdominal pain recurred,
the patient did not have recurrence of fever after hos-
pital day 2. Most convincingly, with adequate control
of her volume status and in the absence of antibiotic
therapy as an outpatient, our patient has had no evi-
dence of cholecystitis.
While diffuse gallbladder wall edema is a known
entity in heart failure, this case demonstrates that it
is not always painless, and a positive sonographic
Murphy sign can be present. Thus, the specificity of
the Murphy sign for acute surgical cholecystitis, even
when seen with wall thickening and in the presence
of gallstones, should be cautiously applied in this
patient population at generally higher surgical risk.
We suspect that the presence of maximal pain directly
over the gallbladder in this case was due in part to ob-
struction of the gallbladder neck from significant sub-
serosal edema.
In conclusion, we have presented an illustrative case
of gallbladder wall thickening and what clinically ap-
peared to be cholecystitis fluctuating in real time with
a patient's volume status and captured by point-of-care
ultrasound. This entity likely represents a portion of
the cases of right upper quadrant abdominal pain in
the setting of CHF previously attributed to hepatic
capsular distention. The pathophysiology is likely the
same as in congestive hepatopathy and treatment in
both cases should be directed at the underlying prob-
lem of volume overload. More importantly, this entity
may also represent a subset of patients with CHF,
bystander gallstones, and a thickened gallbladder wall
who receive potentially unnecessary surgical treatment
for presumed acute gallstone cholecystitis, as almost
happened with our patient and as we have subse-
quently seen in a separate case.
In scenarios such as this, when imaging findings vary
over hours with changes in patient physiology, the
established sensitivity of formal imaging studies may
no longer apply and over-reliance on a negative study
can easily misdirect the differential diagnosis and treat-
ment plan. Point-of-care ultrasound in the hands of a
competent physician caring for the patient, obtained
and interpreted in a known clinical setting, and repeated
as necessary during fluctuations in patient status
provides an invaluable tool for the complex problem
solving frequently encountered by internal medicine
physicians.Consent
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